• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Serum therapy revisited: animal models of infection and development of passive antibo

Mingus

Well-known member
<table border="0" cellpadding="0" cellspacing="3" width="100%"><tbody><tr><td rowspan="1000" background="corehtml/pmc/pmcgifs/wm-aac.gif" height="300" width="20">
</td><td valign="top">
L'article complet gratuit ici
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=7985997

Antimicrob Agents Chemother. 1994 August; 38(8): 1695–1702.
Copyright notice

Serum therapy revisited: animal models of infection and development of passive antibody therapy.
A Casadevall and M D Scharff

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.http://www.flutrackers.com/forum/editpost.php?do=editpost&p=28720
rt-arrow.gif
This article has been cited by other articles in PMC.

Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or see the PubMed citation or the full text of some References or click on a page below to browse page by page.


Selected References

This list contains those references that cite another article in PMC or have a citation in PubMed. It may not include all the original references for this article.
  • Branham, Sara E. THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS). Bacteriol Rev. 1940 Jun;4(2):59–96. [PubMed]
  • Branham, Sara E. SEROLOGICAL RELATIONSHIPS AMONG MENINGOCOCCI. Bacteriol Rev. 1953 Sep;17(3):175–188. [PubMed]
  • Finland, Maxwell.; Ruegsegger, James M. IMMUNIZATION OF HUMAN SUBJECTS WITH THE SPECIFIC CARBOHYDRATES OF TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS . J Clin Invest. 1935 Nov;14(6):829–832. [PubMed]
  • Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. [PubMed]
  • LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4220–4224. [PubMed]
  • MacCordick AH. A STATISTICAL REVIEW OF 525 CASES OF LOBAR PNEUMONIA. Can Med Assoc J. 1931 Dec;25(6):704–706.
  • Morrison SL. In vitro antibodies: strategies for production and application. Annu Rev Immunol. 1992;10:239–265. [PubMed]
  • Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985 Feb;45(2):879–885. [PubMed]
</td></tr></tbody></table>
 
Back
Top